ABSTRACT
Objective According to the theoretic framework of successful ageing,this study developed a multidimensional Successful Ageing Assessment Scale and tested its reliability and validity.Methods Through literature review,the study determined evaluative dimension,structure and scoring method.Then,the Successful Ageing Multidimensional Assessment Scale(SAMAS) was developed and was optimized by the expert consultation,semi-structured interview and twice tests.The predicted sample was conducted with item analysis,and testing of reliability and validity; the formal tested sample was conducted with item analysis,conformance testing and testing of reliability and validity.Then the formal tested sample was tested and retested two weeks later.The intestine emendatory Activities of Daily Living Scale (ADL),Mini Mental State Examination Scale (MMSE),Social Disability Screening Schedule (SDSS) and Memorial University of Newfoundland Scale of Happiness(MUNSH) were used to test its criteri-on validity.Results SAMAS consisted of 5 dimensions,including chronic disease state,physical perfor-mance,cognitive function,social function,subjective well-being.Item analysis showed the dimensions of scale and total scale scores had positive correlation.In conformance testing,the Kappa value was 0.65～0.86,test-retest reliability was 0.66～0.85 and the internal consistency reliability was 0.88.The correl-ative coefficient of the physical performance and social function scores were negatively correlated with ADL scores and SSDS scores,the correlative coefficient of the cognitive function and subjective well-being scores were positively correlated with MMSE scores and MUNSH scores.Conclusions SAMAS suggested good reliability,validity and could well evaluate comprehensive health for the elderly,at the same time could distinguish between SA and non SA group.
ABSTRACT
Objective To observe the effect of atorvastatin on lowering blood lipid in patients with type 2 diabetic mellitus plus hyperlipidemia. Methods All patients took 10 mg atorvastatin every night for 12 months. The levels of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), serum alanine aminotransferase (ALT), aspartate aminotransferase fAST), fasting blood glucose (FBG), creatinine (Cr), intima media thickness (IMT) of carotid artery (CA), common lilac artery (CIA) and femoral artery (CFA) were examined before and 3, 6, 9, 12 months after the treatment. Results TC [(5.11±0.94) vs. (4.46±0.98) mmol/L, P<0.01] and LDL-C [(3.01±0.78) vs. (2.55± 0.83) mmol/L, P<0. 01] were significantly decreased one year after the treatment. At different detection time points, the levels of LDL-C all reached the therapy standard (<2.59 mmol/L). But TC reached the therapy standard (<4.04 mmol/L) only at nine months after the treatment. IMT of CA, CIA and CFA were at the decreased tendency (P>0. 05). No significant changes were observed in ALT, AST and Cr. Conclusions Atorvastatin may significantly decreased the level of blood lipid with little adverse effect in elderly patients with type 2 diabetic mellitus plus hyperlipidemia, and it also has the effect of protecting the vascular intima.